Prevention of oncological diseases in the work of nursing staff

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Cancer prevention is currently divided into primary and secondary prevention. Primary prevention is a set of measures that prevents the development of the cancer process and includes, for example, health counseling and education, environmental control and product safety. Secondary prevention is a set of measures leading to the detection and control of cancer or precancerous processes at their localization, that is, screening, early detection and effective treatment. The risk of developing cancer exists throughout life for everyone, although it can vary in intensity in different groups. Together, primary and secondary prevention should be combined into optimal strategies throughout life that are best understood and evaluated in accordance with certain basic concepts of cancer epidemiology. The purpose of this article is to give a brief overview of these concepts applied to primary and secondary cancer prevention in humans. A deeper understanding of these concepts is essential for planning, implementing and evaluating prevention programs.

Full Text

Restricted Access

About the authors

Vsevolod V. Skvortsov

Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation

Author for correspondence.
Email: vskvortsov1@ya.ru

Doctor of Medical Science, Professor of the Department of Internal Medicine, Federal State Budgetary Educational Institution of Higher Education “Volgograd state medical university” of the ministry of health of the Russian Federation

Russian Federation, Volgograd

Farid Z. Tagiyev

Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation

Email: tagiev057@mail.ru

4th year student of the Faculty of Medicine of FGBOU VO VolgSMU of the Ministry of Health of the Russian Federation

Russian Federation, Volgograd

Kristina A. Durnoglazova

Federal State Budgetary Educational Institution of Higher Education «Volgograd state medical university» of the ministry of health of the Russian Federation

Email: kristina.dunoglazova@mail.ru

a 5th-year student of the Faculty of Medicine of FGBOU VO VolgSMU of the Ministry of Health of the Russian Federation

Russian Federation, Volgograd

References

  1. Волокитина Т.В. Основы медицинских знаний: учеб. пособие для высшей школы / Т.В. Волокитина, Г.Г. Бральнина, Н.И. Никитинская. М.: Академия, 2008. 224 с.
  2. Вайнер Э.Н. Валеология: учебник для вузов. 11-е изд. М.: Флинта: Наука, 2021. 448 с.
  3. Курить — здоровью вредить: Учебно-методическое пособие /АГПИ им. А.П. Гайдара; / Ю.Н. Иванченко, М.В. Пищаева, С.В. Денисова, В.Ю. Маслова. Арзамас: АГПИ, 2004. 60 с.
  4. Основы здорового питания: Учебно-методическое пособие /АГПИ им. А.П. Гайдара; / Ю.Н. Иванченко, М.В. Пищаева, С.В. Денисова, В.Ю. Маслова. Арзамас: АГПИ, 2004. 60 с.
  5. Belialova N.S., Belialov F.I. [Risk factors and prevention of cancer of various localizations. Part II]. Klin Med (Mosk). 2005; 83 (12): 20–24.
  6. Тен Е.Е. Основы медицинских знаний: учебник. 4-е изд. М.: Академия, 2008. 256 с.
  7. Mayne S.T., Lippman S.M. Cigarettes: a smoking gun in cancer chemoprevention. J Natl Cancer Inst. 2005; 97 (18): 1319–1321. doi: 10.1093/jnci/dji306. PMID: 16174848.
  8. Adamowicz K., Zaucha J.M., Majkowicz M. Assessment of the state of knowledge regarding cancer prevention among patients of the Breast Cancer Prevention Clinic Nowotwory. J. Oncol. 2011; 61 (5): 449–456.
  9. Chang J.S., Straif K., Guha N. The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. Mutagenesis 2012; 27 (3): 275–286. https://doi: 10.1093/mutage/ger073
  10. Cogliano V.J., Baan R., Straif K. et al. Preventable exposures associated with human cancers. J. Natl. Cancer. Inst. 2011; 103 (24): 1827–1839. https:// doi: 10.1093/jnci/djr483
  11. Заридзе Д.Г. Профилактика рака. Руководство для врачей. М.: ИМА-ПРЕСС, 2009. 224 с.
  12. Miller AB. The future of cancer prevention. Prev Med. 2012; 55 (6): 554–555. doi: 10.1016/j.ypmed.2012.09.018.
  13. Knight SB, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Progress and prospects of early detection in lung cancer Open Biol. 2017; 7 (9): 170070, https://doi: 10.1098/rsob.170070
  14. Franc EL, et al. Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy. Vaccine. 2012; 30 (5): F175–F182, https://doi: 10.1016/j.vaccine.2012.06.092
  15. Demarco M. et al. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing. J. Clin. Microbiol. 2018; 56 (5): e01910–17, https:// doi: 10.1128/JCM.01910-17
  16. Alemar B., Gregório C., Herzog J. et al. BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population? PLoS One. 2017; 12 (11): e0187630, https://doi: 10.1371/journal.pone.0187630
  17. Meyskens F.L. Jr., Mukhtar H., Rock C.L. et al. Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst. 2015; 108 (2): djv309. doi: 10.1093/jnci/djv309.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies